glp-1 microdose tirzepatide What Is Microdosing GLP-1? Full Guide Tirzepatide Microdose Program | Fierce

While initially designed for type 2 diabetes, several GLP-1 medications are now FDA-approved for weight management in non-diabetic individuals

Hsieh M-J, Lee C-H, Chueh H-Y, Chang G-J, Huang H-Y, Lin Y, et al

Brand-Name FDA-Approved Medications Referenced on altRx altRx's source materials also reference brand-name FDA-approved medications at separate listed price points: Mounjaro: Listed at $1,249 per month per altRx's source materials Ozempic: Listed at $1,149 per month per altRx's source materials Wegovy: Listed at $1,579 per month per altRx's source materials Zepbound: Listed at $1,249 per month per altRx's source materials According to altRx's published trademark notice, Wegovy is FDA-approved for weight loss, and Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed for weight loss at the discretion of a clinician

doi:10.1016/j.eurger.2017.01.002

Statistical Analysis Data were described as median (range) for quantitative and by frequencies and percentages for qualitative